• SENSEX 74,314.59
    -21.86 (--0.03%)
  • BANKNIFTY 56,292.45
    497.70 (+0.89%)
  • HDFC Bank
    713.00 682.00(%)
  • Kanohar Elect.
    885.65 786.95(%)
  • A B B
    7,161.10 7,923.35(%)
  • Reliance Industries
    1,238.20 1,236.00(%)
  • PB Fintech.
    1,719.30 1,334.20(%)
  • Gland Pharma
    2,940.90 3,041.95(%)
  • Glass Wall Syst.
    258.40 228.10(%)
  • Tata Chemicals
    831.00 1,026.00(%)
  • IFCI
    80.95 107.45(%)
  • ICICI Bank
    1,345.00 1,187.55(%)
  • Solar Industries
    18,600.00 11,641.10(%)
  • Entero Healthcar
    1,614.00 944.00(%)
  • JSW Infrast
    329.55 355.65(%)
  • Bharti Airtel
    1,827.05 1,745.00(%)
  • Larsen & Toubro
    3,875.00 4,440.00(%)
  • Syrma SGS Tech.
    1,658.40 1,676.15(%)
  • Molbio Diagnosti
    1,270.60 925.80(%)
  • TVS Motor Co.
    4,162.80 4,484.70(%)
  • Nippon Life Ind.
    1,107.05 756.10(%)
  • SBI
    984.50 821.60(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Mangalam Drugs and Organics Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 20249.0
  • ISIN : INE584F01014
31.98 -2 (-4.65%)
  • As on 17 Sep 2026 (EOD)

  • Today’s Low

    31.20

  • Today’s High

    33.79

  • Open

    33.00

  • Perv Close

    33.54

  • 52W Low

    22.80

  • 52W High

    77.60

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    50.62

  • Div & Yield %

    0.00

  • Book Value(₹)

    65.27

  • Debt-Equity Ratio

    -4.65

  • AGM Date

    16-Sep-2026

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    0.79

  • Mar.Cap (₹Cr.)

    50.62

  • RONW (%)

    -6.68

  • ROCE (%)

    1.16

Score Board

  • Equity (₹ in Cr.)

    15.83

  • BV (₹)

    65.30

  • Sales( ₹ in Cr.)

    232.13

  • NP (in Cr.)

    -43.81

  • NP Var(%)

    -738.0

  • Div%

    0.0

  • CPS (₹)

    -16.40

  • EPS (₹)

    -27.70

  • Traded Value (₹ in Lakhs)

    50.65

  • 52 Week High

    77.60

  • 52 Week Low

    22.80

  • Price BSE

    32.0

  • Price NSE

    32.00

  • Market Capital( in Cr.)

    50.65

  • P/C Ratio

    -2.00

  • P/E Ratio

    -1.20

  • Price Vs.BV

    -27.70

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 318.23 368.59 372.25 451.07 379.98 313.13
Excise Duty 0.00 0.00 0.00 0.00 0.00 30.78
Net Sales 318.23 368.59 372.25 451.07 379.98 282.35
Other Income 0.50 0.12 0.44 0.09 4.72 1.18
Stock Adjustments 21.52 -9.10 42.16 33.75 4.23 -17.28
Total Income 340.25 359.61 414.85 484.91 388.93 266.25
EXPENDITURE :            
Raw Materials 188.89 235.41 292.60 340.39 256.19 178.07
Power and Fuel Cost 27.88 28.50 25.59 22.90 16.12 14.24
Employee Cost 40.59 39.07 34.61 37.25 29.88 26.04
Other Manufacturing Expenses 18.36 13.26 11.58 11.92 8.11 7.37
Selling and Administration Expenses 14.13 13.10 11.60 13.64 16.19 14.24
Miscellaneous Expenses 14.10 12.78 12.71 9.67 4.42 1.42
Employee Benefit Expenses 40.59 39.07 34.61 37.25 29.88 26.04
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 303.95 342.12 388.69 435.77 330.91 241.38
Operating Profit 36.30 17.49 26.16 49.14 58.02 24.87
Interest 14.93 13.92 12.96 11.16 9.33 10.40
Gross Profit 21.37 3.57 13.20 37.98 48.69 14.47
Depreciation 16.38 14.63 10.99 10.25 9.18 8.22
Profit Before Tax 4.99 -11.06 2.21 27.73 39.51 6.25
Current Tax 0.08 0.19 -0.03 8.81 9.27 0.05
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -2.02 -2.20 0.97 -0.73 2.28 -2.05
Reported Net Profit 6.92 -9.05 1.27 19.66 27.97 8.25
Extraordinary Items 0.06 -0.05 0.00 0.06 0.00 -0.04
Adjusted Net Profit 6.86 -9.00 1.27 19.60 27.97 8.29
Adjustment below Net Profit -0.62 -0.56 0.12 0.12 -1.12 0.02
P & L Balance brought forward 93.35 102.96 101.57 81.79 54.94 46.67
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 99.66 93.35 102.96 101.57 81.79 54.94
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 4.37 -5.72 0.80 12.42 17.67 5.21
Earnings Per Share(Adj)-Unit Curr 4.37 -5.72 0.80 12.42 17.67 5.21
Book Value 93.92 89.93 96.00 95.12 82.63 65.67
Book Value(Adj)-Unit Curr 93.92 89.93 96.00 95.12 82.63 65.67

Shareholding Pattern

  • Promoter Group

    35.65%

  • Public Share Holding

    64.35%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 2,632,682 16.63 2,632,682 4
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 3,010,348 19.02 3,010,348 14
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 5,643,030 35.65 5,643,030 18
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 306 0.00 306 2
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 17,505 0.11 17,505 1
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 17,811 0.11 17,811 3
2] Non Institution
Bodies Corporate 134,235 0.85 134,235 65
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 197,660 1.25 197,660 341
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 236,976 1.50 236,976 338
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,633,861 10.32 1,633,861 39
Individuals holding nominal share capital up to Rs. 1 lakh 7,943,787 50.19 7,943,787 23,641
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 14,057 0.09 14,057 12
Sub Total 10,167,407 64.24 10,167,407 24,444
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 15,828,248 100.00 15,828,248 24,465

Company Background

Mangalam Drugs and Organics LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Mangalam Drugs and Organics Ltd
  • BSE Code : 20249.0
  • ISIN : INE584F01014

  • Incorporation Year

    1972

  • Registered Office

    3rd Floor Rupam Building
    239 P D Mello Road, Mumbai,
    Maharashtra-400001

  • Telephone

    91-22-22616200/6300/8787

  • FAX

    91-22-26190900

  • Chairman

    Govardhan M Dhoot

  • Managing Director

    Govardhan M Dhoot

  • Company Secretary

  • Auditor

    V S Somani & Co/S N Nanda & Co

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Mangalam Drugs and Organics Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Mangalam Drugs 32.00 318.73 318.23 -1.35 7.94
Abbott India 26,118.60 7,217.19 6,929.05 34.37 43.78
Astrazeneca Phar 6,710.80 2,304.07 2,275.58 98.91 27.86
Glaxosmi. Pharma 2,853.85 3,932.76 3,790.20 45.59 58.17
Novartis India 1,996.85 393.10 354.33 50.43 15.94
Cipla 1,359.75 20,102.60 18,979.95 35.74 13.88
Bliss GVS Pharma 679.90 773.53 729.81 63.19 12.51
Amrutanjan Healt 489.60 520.13 502.55 26.22 24.16
Fermenta Biotec. 468.85 474.15 450.25 21.89 18.77
Guj. Themis Bio. 412.35 168.25 165.82 110.25 18.05
Ambalal Sarabhai 39.36 19.52 3.94 72.89 6.77